Chris Lyon Joins NATROX® Wound Care as VP Sales, North America
Chris joins at a key time of growth for the company which is rapidly expanding product access worldwide with an intense focus on the USA market. Chris will be responsible for implementing sales strategy, developing product reimbursement strategy across the USA, and penetrating new market segments to drive organisational growth and profitability.
“We’re excited to have Chris onboard because he’s a results-driven leader with an extensive background helping medical device start-ups deliver on their goals,” said Craig Kennedy, CEO of NATROX® Wound Care. “His knowledge of the wound care market and passion for improving patient outcomes makes him a perfect fit. We’re expecting a banner year ahead, and Chris will be paramount in propelling us forward.”Read More
Dr. Windy Cole, DPM Joins NATROX® Wound Care as Director of Global Medical Affairs
NATROX® Wound Care is excited to announce that Dr. Windy Cole, DPM will join as Director of Global Medical Affairs. She joins at a critical juncture as the company increases product availability worldwide and seeks to develop new solutions to improve chronic wound patient outcomes. Dr. Cole will be responsible for developing and overseeing medical strategy, strengthening strategic partnerships among key opinion leaders (KOLs), and advancing clinical evidence to support industry recognition of advanced wound therapies.
“Windy is an outstanding addition,” said Craig Kennedy, NATROX® Wound Care CEO. “She’s been on the forefront of wound research and has dedicated her career to advancing wound care. We first collaborated with Windy as a Principal Investigator (PI) in our clinical trials investigating the impact of topical oxygen therapy on chronic DFUs. Her profound passion for helping others aligns perfectly with our mission to transform patients’ lives.”Read More
Nancy Stahulak Joins NATROX® Wound Care as VP of Global Marketing
NATROX® Wound Care announces Nancy Stahulak as Vice President (VP) of Global Marketing. She joins the team as it is expanding product access worldwide and expects to continue making inroads towards product reimbursement in the USA. Nancy will be responsible for developing and implementing a global marketing strategy, strengthening the company’s brand position, and generating growth through clinician engagement.
“Nancy is a strategic, customer-focused marketing leader with a proven track record for driving top-line growth and long-term market sustainability,” said Craig Kennedy, CEO of NATROX® Wound Care. “She is a perfect fit coming from Medela, as it gives her a solid understanding of the challenges facing the wound care industry and a deep understanding of our customers.”Read More
John Adam Joins NATROX® Wound Care as Chief Operating Officer
NATROX® Wound Care is pleased to announce the appointment of John Adam to take the role of Chief Operating Officer (COO). He will support the leadership team in executing the company’s vision of transforming the lives of patients suffering from hard-to-heal wounds through innovative technology. John will assume responsibility for manufacturing operations, quality, and product development to optimise the way NATROX® delivers an excellent customer experience to its global client base.Read More
Dr. Thomas Serena Joins NATROX® Wound Care Team as Chief Medical Officer
NATROX® Wound Care is excited to announce the addition of Dr. Thomas Serena, MD FACS FACHM MAPWCA, who joins as Chief Medical Officer (CMO) effective immediately. The internationally recognised expert in the field of wound healing has been the lead or Principal Investigator in over 100 clinical trials. He has a vast knowledge of oxygen therapy and understands its positive impact on chronic wounds.
“Having Tom onboard adds tremendous clinical credibility around the wound care benefits of topical oxygen,” said Craig Kennedy, CEO. “Tom will be supporting our strategy to making NATROX® O₂ readily available to all patients, which includes securing USA reimbursement.”Read More
NATROX® Wound Care Appoints Eminent Wound Care and Biofilm Expert, Dr. Gregory Schultz, as Chief Scientific Officer
“Dr. Schultz is a fantastic addition to our team and adds scientific credibility to our technologies. His knowledge and experience will be invaluable as we continue to grow our innovative oxygen therapy business and develop next-generation technologies aimed at supporting clinicians and empowering patients who suffer from chronic wounds.”Read More
Inotec AMD Announces New Director of Human Resources to Support Global Team
Sandy Fliri-Marx brings 20 years international expertise to advance corporate expansion plans. Having worked in Senior HR Management for leading biotechnology companies, Fliri-Marx has developed successful HR strategies for organizations of varying sizes with locations across the globe. The role is pivotal for Inotec, a young, growing company currently expanding its workforce to meet increased manufacturing demands.Read More
Jane Clark, VP Global Marketing & Clinical Affairs, in Top 25 Women Leaders in Medical Devices 2021
Jane Clark, VP Global Marketing and Clinical Affairs has been recognised as one of the Top 25 Women Leaders in Medical Devices of 2021 by The Healthcare Technology Report. According to The Healthcare Technology Report “Jane stood out for her depth of specialized knowledge and overall impact on her organization as well as the medical device field. Jane brings both executive and clinical experience to her current role, including a tenure as a tissue viability specialist within the UK’s National Health Service (NHS).Read More
Craig Kennedy, Inotec AMD, included in the 10 Best Inspiring CEOs of 2020
Craig Kennedy, Inotec AMD’s CEO, has been included in the 10 Best Inspiring CEOs of 2020 according to Industry Era.Read More
Patrick Barron, VP Operations, wins a prestigious award
Patrick Barron, Inotec AMD VP of Operations, has been recognised as one of the Top 100 most inspirational individuals working in UK industry by the The Manufacturer magazine.Read More